Study on the Detection of Pleuropulmonary Manifestations in Rheumatoid Arthritis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMedical University Innsbruck
About this trial
The aim of the study is to develop a standardized, risk-adapted screening protocol for detecting pleuropulmonary manifestations in patients with rheumatoid arthritis. To assess the risk of these manifestations, a comprehensive range of functional and clinical evaluations will be performed and correlated with structural lung assessments using computed tomography (CT).
Eligibility criteria
Qualifiers
Patients ≥18 years diagnosed with rheumatoid arthritis according to current ACR/EULAR criteria
Residence in Austria
Signed and dated consent of the patient in accordance with ICH-GCP guidelines
Disqualifiers
pregnancy
age below 18 years
Contraindications to study-related routine examinations (e.g., inability to draw blood due to needle phobia, no CT scan possible due to claustrophobia, pregnancy, etc.)
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov